ARTICLE | Finance
A Japanese correction
Japanese biotechs see large correction but still up since January 2013
February 10, 2014 8:00 AM UTC
Japan's biotechs exhibited the high beta typical of the sector last week, falling more than five times as much as the country's broader markets, which themselves have been taking a beating. Nevertheless, Japanese biotechs still have far outperformed the market over the last 13 months.
An equal price-weighted index of 29 Japanese biotechs fell as much as 24% last week before closing down 16%. Every biotech in the index was down...